COCH
Envoy Medical, Inc.Company with tickers: COCH, COCHW
CIK
1840877
CUSIP
29415V109
Shares Outstanding
76,881,110
13F Activity (30d)
29 filings
28 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $39,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $313,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $3,642,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $-5,959,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-4,351,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-0.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-0.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |